In this article, we will be looking at the 5 stocks billionaire David Harding is currently buying. If you want to see our comprehensive analysis of Harding’s history, investment philosophy and hedge fund performance, go directly to Billionaire David Harding is Buying These 10 Stocks.
5. Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Winton Capital Management’s Stake Value: $1.46 million
Percentage of Winton Capital Management’s 13F portfolio: 0.08%
Total Number of Hedge Fund Holders: 47
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) deals in the design, manufacture and supply of musculoskeletal products around the globe. These include orthopedic reconstructive products, such as hip and knee replacement products, as well as devices used for rehabilitative purposes during surgery.
On November 23, research firm Argus downgraded the company’s stock from ‘Buy’ to ‘Hold’. The company has suffered from the spread of the Delta variant and a ban on elective surgeries in most parts of the world. The firm’s analyst David Toung added that pricing cuts in China were also pressuring gross and operating margins.
In the third quarter of 2021, Zimmer Biomet Holdings, Inc. (NYSE: ZBH) posted an EPS of $1.81, beating estimates by $0.05.
Out of 867 hedge funds tracked by Insider Monkey, 47 reported owning shares in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by end of September. The combined value of these holdings stood at $1.66 billion.
4. Sharps Compliance Corp. (NASDAQ:SMED)
Winton Capital Management’s Stake Value: $139,000
Percentage of Winton Capital Management’s 13F portfolio: Less than 0.01%
Total Number of Hedge Fund Holders: 12
Sharps Compliance Corp. (NASDAQ: SMED) is a company that deals in the processing of medical, pharmaceutical, and hazardous waste in the United States. According to the Q3 data, David Harding recently acquired 16,752 shares in the company, valued at $139,000.
The firm posted an EPS of -$0.04, missing estimates by -$0.01. For the third quarter, revenue stood at $13.91 million, beating expectations by $0.53 million
In November, Sharps Compliance Corp. (NASDAQ: SMED) acquired Affordable Medical Waste for $2.2 million. AMW is a full-service, route-based provider of waste management services. The deal allows Sharps Compliance Corp. (NASDAQ: SMED) access to over 500 customer locations in the Midwest region, primarily Indiana.
On November 3, research firm Barrington maintained an ‘Outperform’ rating on the company stock, lowering the price target from $13 to $11.
12 hedge funds in Insider Monkey’s database reported owning shares in Sharps Compliance Corp. (NASDAQ: SMED) by the end of September.
3. Airbnb, Inc. (NASDAQ:ABNB)
Winton Capital Management’s Stake Value: $3.04 million
Percentage of Winton Capital Management’s 13F portfolio: 0.17%
Total Number of Hedge Fund Holders: 58
Next up is Airbnb, Inc. (NASDAQ: ABNB), ranking on the list of stocks billionaire David Harding is buying. The company is a household name in many parts of the world, providing an online marketplace that connects homeowners to travelers looking for lodging and accommodation.
As of the third quarter of 2021, 58 hedge funds out of 867 tracked by Insider Monkey reported owning positions in Airbnb, Inc. (NASDAQ: ABNB), with a combined value of $2.71 billon.
The company posted an EPS of $1.22 for Q3 2021, beating estimates by $0.52. Airbnb, Inc. (NASDAQ: ABNB) raked in $2.24 billion in revenue for the quarter, beating analysts’ forecasts by $181.63 million.
On November 8, Truist analyst Naveed Khan kept a ‘Hold’ rating on the company’s shares, raising the price target to $180 from $160. The company is expected to grow strongly as international travel resumes after the gradual easing of travel restrictions.
2. Myovant Sciences Ltd. (NYSE:MYOV)
Winton Capital Management’s Stake Value: $287,000
Percentage of Winton Capital Management’s 13F portfolio: 0.01%
Total Number of Hedge Fund Holders: 13
Myovant Sciences Ltd. (NYSE: MYOV) is next on David Harding’s radar, a growing biopharmaceutical company that deals in the development of therapies for the treatment of women’s health and endocrine diseases.
By the end of September, the company reported an EPS of -$0.23, beating estimates by $0.17. For the third quarter, revenue stood at $77.90 million, surpassing expectations by $6.09 million.
In Q3 2021, 13 hedge funds out of 867 tracked by Insider Monkey disclosed ownership in Myovant Sciences Ltd. (NYSE: MYOV), with a combined value of $40.73 million. This is in comparison to the previous quarter where 18 hedge funds held $103.19 million worth of shares in the bio-pharmaceutical company.
1. The Aaron’s Company, Inc. (NYSE:AAN)
Winton Capital Management’s Stake Value: $533,000
Percentage of Winton Capital Management’s 13F portfolio: 0.02%
Total Number of Hedge Fund Holders: 17
The Aaron’s Company, Inc. (NYSE: AAN) is a provider of lease-to-own and purchase services for a range of furniture, home appliances, electronics and accessories throughout the United States and Canada. It operates approximately 1300 company operated stores overall, and provides services through its e-commerce platform as well.
Out of 867 hedge funds tracked by Insider Monkey, 17 reported holding stakes in The Aaron’s Company, Inc. (NYSE: AAN) by the end of September. The total value of these holdings was $67.83 million, down from $85.41 million held by 15 hedge funds a quarter earlier.
The company reported earnings per share of $0.83 for Q3 2021, beating estimates by $0.26. Revenue for the quarter was $452.15 million, which surpassed consensus estimates by $20.90 million.
You can also take a peek at the 25 Fastest Growing Cities In the US and 10 Best Dividend Stocks for Passive Income
